JOINT FILING AGREEMENTJoint Filing Agreement • February 5th, 2024 • Eastspring Investments (Singapore) LTD • Laboratory analytical instruments
The undersigned hereby agree that the statement on Schedule 13G with respect to Common Stock of Prenetics Global Limited dated as of 29 December 2023 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Exhibit 99 Joint Filing Agreement The undersigned hereby agree that the statement on Schedule 13G with respect to Common Stock of Prenetics Global Limited dated as of 30 September 2024 is, and any amendments thereto (including amendments on Schedule...Joint Filing Agreement • November 7th, 2024 • Eastspring Investments (Singapore) LTD • Laboratory analytical instruments
The undersigned hereby agree that the statement on Schedule 13G with respect to Common Stock of Prenetics Global Limited dated as of 30 September 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
JOINT FILING AGREEMENTJoint Filing Agreement • February 8th, 2023 • Eastspring Investments (Singapore) LTD • Laboratory analytical instruments
The undersigned hereby agree that the statement on Schedule 13G with respect to Common Stock of Prenetics Global Limited dated as of 30 December 2022 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
JOINT FILING AGREEMENTJoint Filing Agreement • June 8th, 2022 • Eastspring Investments (Singapore) LTD • Laboratory analytical instruments
The undersigned hereby agree that the statement on Schedule 13G with respect to Common Stock of Prenetics Global Limited dated as of 31 May 2022 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
